Bidding farewell to 2011 will likely be a welcome occasion for most folks in the med-tech industry as the year presented its fair share of regulatory road blocks and other challenges. Heading into 2012, the med-tech analysts at Canaccord Genuity (Toronto) have identified their top picks for 2012.